Concepedia

Anders Poulsen

AP

Statistics

Publications

57

Citations

2.9K

H-Index

31

Active since

1969

Affiliations

Experimental Drug Development Centre(Current)

Agency for Science, Technology and Research

National University of Singapore

Singapore Science Park

Nanyang Technological University

Anders Poulsen is an author at Experimental Drug Development Centre specializing in drug discovery, pharmacology, and medicinal chemistry.

ORCID

Publications per year

1969–2021

57

Publications

57

Targeting the Central Pocket in Human Transcription Factor TEAD as a Potential Cancer Therapeutic Strategy

Ajaybabu V. Pobbati, Xiao Han, Alvin W. Hung et al. · Structure · 2015 · 204 citations · Full text

, , +13

SB1518, a novel macrocyclic pyrimidine-based JAK2 inhibitor for the treatment of myeloid and lymphoid malignancies

Stefan Hart, K C Goh, Veronica Novotny‐Diermayr et al. · Leukemia · 2011 · 199 citations · Full text

, , +16

Discovery of the Macrocycle 11-(2-Pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene (SB1518), a Potent Janus Kinase 2/Fms-Like Tyrosine Kinase-3 (JAK2/FLT3) Inhibitor for the Treatment of Myelofibrosis and Lymphoma

Anthony D. William, Angeline C.-H. Lee, Stéphanie Blanchard et al. · Journal of Medicinal Chemistry · 2011 · 198 citations · Full text

, , +17

Hydrogen‐tritium exchange of the random chain polypeptide

S. Walter Englander, Anders Poulsen · Biopolymers · 1969 · 176 citations

, , +17

SIRT1 Modulating Compounds from High-Throughput Screening as Anti-Inflammatory and Insulin-Sensitizing Agents

Vasantha M. Nayagam, Xukun Wang, Yong Tan et al. · SLAS DISCOVERY · 2006 · 147 citations · Full text

, , +17

1–5 of 57